课题基金 / 基金详情

PHOTOTHERAPY OF MURINE OVARIAN CANCER BY HEMATOPORPHYRIN DERIVATIVE

PHOTOTHERAPY OF MURINE OVARIAN CANCER BY HEMATOPORPHYRIN DERIVATIVE
血卟啉衍生物对小鼠卵巢癌的光疗
批准号:
3963251
负责人:
A RUSSO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

A RUSSO的其他基金

相关文献

中文摘要
翻译
血卟啉衍生物(HPD)与红光组合的用途 目前正在研究作为一种抗癌治疗方式。 一 这种疗法的主要优点是据称的肿瘤选择性, 与正常组织反应相比。 已经设计了研究, 目前正在建立HPD在肿瘤和正常组织中的保留 在小鼠模型中。 一种源自小鼠的卵巢肿瘤模型 用于确定HPD的药效学,优化HPD 递送、激光穿透、光和药物递送到 腹膜腔。 使用不同波长的光 腹水瘤模型研究。 来自卵巢和肺的人异种移植物 正在裸鼠身上进行研究。 单线态氧的测量 为剂量测定做准备。 犬腔内毒性 HPD和激光正在研究中。
英文摘要
The use of hematoporphyrin derivative (HPD) in combination with red light is currently under investigation as an anti-cancer treatment modality. A major advantage of this therapy is the purported selectivity of tumor versus normal tissue response. Studies have been designed and are currently underway to establish HPD retention in tumor versus normal tissue in a murine model. An ovarian tumor model originating from a mouse has been used to determine the pharmacodynamics of HPD, optimization of HPD delivery, laser penetration, dose and timing of light and drug deliver into the peritoneal cavity. The use of different wavelengths of light is being studied on the ascites tumor model. Human xenografts from ovarian and lung are being studied in nude mice. Measurement of singlet oxygen is being studied to prepare the way for dosimetry. Dog toxicity to intracavitary HPD and laser light is being studied.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTRACELLULAR MODULATION OF SPECIFIC INTRACELLULAR PROTEINS
RELATIONSHIP OF CELLULAR REDOX STATE AND THERMOTOLERANCE
  • 批准号:
    3939515
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    A RUSSO
  • 依托单位:
INTRACELLULAR MODULATION OF SPECIFIC INTRACELLULAR PROTEINS
  • 批准号:
    3752415
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    A RUSSO
  • 依托单位:
DEVELOPMENT OF SUPEROXIDE DISMUTASE MIMICS
  • 批准号:
    3774576
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    A RUSSO
  • 依托单位: